Skip to main content

Rockefeller University Grants Rosetta Genomics Rights to Study Its microRNAs

NEW YORK (GenomeWeb News) - Rosetta Genomics has licensed from Rockefeller University the right to access nearly 180 of its microRNAs, Rosetta said today.
 
Rosetta said it will add these microRNAs to its existing microRNA database, which could arm it with additional biomarker candidates for its diagnostic development programs.
 
Rosetta has discovered nearly 360 biologically validated human microRNAs and the Rockefeller agreement will enable it to study 530 of the 660 publicly confirmed microRNA genes in the entire human genome, the company said.
 
The company will use the microRNAs to "potentially advance multiple" research development programs targeting new microRNA-based diagnostic tools for a "variety" of diseases.
 
Terms of the agreement call for Rosetta Genomics to pay Rockefeller University an initiation fee as well as maintenance fees and royalties.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.